Clinical trial
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
NCT04624685 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
- Lead sponsor
- Glaukos Corporation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 15, 2020
- Completion date
- December 31, 2021
- Enrollment
- 475 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.